000 01540 a2200385 4500
005 20250516190438.0
264 0 _c20140422
008 201404s 0 0 eng d
022 _a1083-351X
024 7 _a10.1074/jbc.M113.487736
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aHoffmann, Gesine
245 0 0 _aA novel sirtuin 2 (SIRT2) inhibitor with p53-dependent pro-apoptotic activity in non-small cell lung cancer.
_h[electronic resource]
260 _bThe Journal of biological chemistry
_cFeb 2014
300 _a5208-16 p.
_bdigital
500 _aPublication Type: Journal Article; Research Support, Non-U.S. Gov't
650 0 4 _aAcetylation
_xdrug effects
650 0 4 _aApoptosis
_xdrug effects
650 0 4 _aCarcinoma, Non-Small-Cell Lung
_xdrug therapy
650 0 4 _aDrug Screening Assays, Antitumor
650 0 4 _aEtoposide
_xpharmacology
650 0 4 _aGene Expression Regulation, Neoplastic
_xdrug effects
650 0 4 _aHistone Deacetylase Inhibitors
_xchemistry
650 0 4 _aHumans
650 0 4 _aInhibitory Concentration 50
650 0 4 _aLung Neoplasms
_xdrug therapy
650 0 4 _aNeoplasm Proteins
_xgenetics
650 0 4 _aSirtuin 2
_xantagonists & inhibitors
650 0 4 _aTumor Suppressor Protein p53
_xmetabolism
700 1 _aBreitenbücher, Frank
700 1 _aSchuler, Martin
700 1 _aEhrenhofer-Murray, Ann E
773 0 _tThe Journal of biological chemistry
_gvol. 289
_gno. 8
_gp. 5208-16
856 4 0 _uhttps://doi.org/10.1074/jbc.M113.487736
_zAvailable from publisher's website
999 _c23406428
_d23406428